Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:36 AM UTC
| NCT Number | NCT06609226 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE3 |
| Target Enrollment | 480 participants |
| Active Locations | 39 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of July 20, 2026: Clinical trial NCT06609226 is currently recruiting participants. This phase3 study for sickle cell disease is actively seeking new participants at 39 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06609226 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 39 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06609226 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.